TRAF6 and osteoporosis: Elevated RANKL levels, as observed in osteoporosis, lead to enhanced TRAF6-mediated signaling, promoting osteoclastogenesis and bone resorption (Yu et al., 2021; Li et al., 2024; Chen et al., 2019).